tiprankstipranks

Bruce Wesson Insider Profile

4 Followers
Bruce Wesson, Director at MedAssets, holds 829.55K shares in Acura Pharmaceuticals (Ticker: ACUR), holds 0.00 shares in MedAssets (Ticker: MDAS), holds 94.96K shares in Derma Sciences (Ticker: DSCI).
tipranks
Bruce Wesson

Bruce Wesson
MedAssets (MDAS)
Director

Ranked #80,917 out of 97,825 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-33.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$41K
100.00%
A breakdown of Bruce Wesson's holdings

Insider Roles

Acura Pharmaceuticals
(ACUR)
Director, Director Emeritus
Roles that Bruce Wesson holds in companies

Most Profitable Insider Trade

Stock:
Derma Sciences
(DSCI)
Rating:Informative Buy
Date:Aug 14, 2015 - Aug 14, 2016
Return:-17.40%
The most profitable trade made by Bruce Wesson

Bruce Wesson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MDAS
MedAssets
Jan 27, 2016
Uninformative Sell
$0.00
DSCI
Derma Sciences
Aug 14, 2015
Informative Buy
65.80K
$664.74K
Acura Pharmaceuticals
Jan 02, 2024
Director, Director Emeritus
Uninformative Buy
$41.48K
~CHMT
Chemtura
$2.53M
List of latest transactions for each holding click on a transaction to see Bruce Wesson's performance on stock

Bruce Wesson insider profile FAQ

What is the percentage of profitable transactions made by Bruce Wesson?
The percentage of profitable transactions made by Bruce Wesson is 0%.
    What is the average return per transaction made by Bruce Wesson?
    The average return per transaction made by Bruce Wesson is -33.90%.
      What stocks does Bruce Wesson hold?
      Bruce Wesson holds: MDAS, DSCI, ACUR, ~CHMT stocks.
        What was Bruce Wesson’s latest transaction?
        Bruce Wesson latest transaction was an Uninformative Buy of ―.
          What was Bruce Wesson's most profitable transaction?
          Bruce Wesson’s most profitable transaction was an Informative Buy of DSCI stock on August 14, 2015. The return on the trade was -17.40%.
            What is Bruce Wesson's role in MedAssets?
            Bruce Wesson's role in MedAssets is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.